J&J | Stammkapital



Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2024-12
Abbott USD 25.12B 28M 2025-03
Amgen USD 33.58B 45M 2025-03
AstraZeneca USD 388M 0 2025-03
Baxter International USD 683M 0 2024-12
Bayer EUR 2.52B 0 2025-03
Becton, Dickinson and Co. USD 371M 0 2025-03
Biogen USD 100K 0 2025-03
Boston Scientific USD 17M 0 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
CONMED USD 313K 0 2025-03
Cooper Companies USD 21.8M 100K 2025-04
Dexcom USD 400K 0 2025-03
Edwards Lifesciences USD 654.8M 500K 2024-12
Eli Lilly USD 592.6M 200K 2025-03
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Globus Medical USD 135K 2K 2025-03
Hologic USD 3M 0 2025-03
Indivior 62M 0 2025-03
Insulet USD 100K 0 2025-03
Integra LifeSciences USD 921K 5K 2025-03
Intuitive Surgical USD 358.42M 358.02M 2025-06
J&J USD 3.12B 0 2025-03
Medtronic USD 128K 128K 2025-04
Merck USD 1.79B 0 2025-03
Merit Medical Systems USD 718.11M 14.89M 2025-03
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Roche Holding CHF 107M 0 2024-06
Sanofi 1.25B 52.53M 2025-03
Stryker USD 38M 0 2025-03
Tandem Diabetes Care USD 67K 1000 2025-03
Teva Pharmaceutical Industries USD 58M 0 2024-09
Vertex Pharmaceuticals USD 2.6M 0 2024-12
Zimmer Biomet Holdings USD 3.2M 0 2024-12
Zoetis USD 5M 0 2025-03


J&J Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.